However, our findings suggest that adiponectin levels should be interpreted holistically, considering CKD stage or dialysis modality, concurrent metabolic parameters, and comorbidities, rather than focusing solely on absolute adiponectin values. This evidence concerns the gene ADIPOQ and chronic kidney disease.